Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...tis, endocarditis, osteomyelitis, severe sepsis, and toxinoses such as toxic shock syndrome. A multifactorial range of independent risk factors for MRSA has been reported in literature and include immunosuppression,hemodialysis, peripheral malperfusion, advanced age, extended in-hospital stays, residency in long-term care facilities (LTCFs), inadequacy of antimicrobial therapy,indwelling devices, insulin-requiring diabetes, and decubitusulcers, among others.
Hindawi Canadian Journal of Infectious Diseases and Medical Microbiology Volume 2019, Article ID 8321834, 9 pageshttps://doi.org/10.1155/2019/8321834
more
Ainsi, le présent profil peint le faciès épidémiologique du pays pour l’année 2015
avec un clin d’œil sur le niveau de réalisation des Objectifs du millénaire pour le
développement (OMD) et un focus particulier sur l’appropriation des Objectifs de
développement durable (ODD). Il e...st composé de six chapitres que sont (i)
Introduction au contexte du pays ; (ii) Etat et tendance des indicateurs de santé ; (iii)
Système de santé ; (iv) Progrès des objectifs de développement durable ; (v)
Programmes et services spécifiques ; (vi) Déterminants clés de la santé.
C’est un outil recommandé par l’OMS et est indispensable pour le pays en prélude à
la mise en place de l’Observatoire national de la santé. Son élaboration a connu un
processus participatif avec l’implication des différents acteurs intervenant dans le
domaine de la santé.
Profil sanitaire complet du Burkina Faso 2015 Page 8
Le document du profil pays a été organisé en 4 modules à savoir :
Module 1 : La situation socio-sanitaire du Burkina Faso et mise en œuvre des ODD ;
Module 2 : Le Système de santé au Burkina Faso ;
Module 3 : Les programmes et services spécifiques de santé au Burkina Faso ;
Module 4 : Les déterminants clés de la santé.
more
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...dicates that the elimination of sleeping sickness ‘as a public health problem’ by 2020 is well within reach. In particular, fewer than one thousand new cases were reported in 2018, and the area where the risk of infection is estimated as moderate, high or very high has shrunk to less than 200,000 km2. More than half of this area is in the Democratic Republic of the Congo. The interruption of transmission of the gambiense form, targeted by the World Health Organization (WHO) for 2030, will require renewed efforts to tackle a range of expected and unexpected challenges. The rhodesiense form of the disease represents a small part of the overall HAT burden. For this form, the problem of under detection is on the rise and, because of an important animal reservoir, the elimination of disease transmission is not envisioned at this stage.
more
Preparedness planning is essential in order to respond effectively to outbreaks, including single case occurrences of highconsequence infectious diseases (HCID), such as the importation of a viral haemorrhagic fever (VHF) case
Le présent guide pratique de prise en charge du paludisme grave et de ses complications est la troisième révision et actualisation de l'ouvrage. Il est destiné prioritairement aux professionnels de santé; travaillant dans des hôpitaux ou des centres de santé disposant de structures d'hospital...isation et qui prennent en charge les malades atteints de paludisme grave. Ce manuel porte principalement sur les aspects pratiques de cette prise en charge, il se fonde sur les directives et les recommandations adoptées au titre de principes
standards de l'OMS.
more
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re...vision of the recommendation regarding the use of 80% fraction of inspired oxygen (high FiO2) in surgical patients under general anaesthesia with tracheal intubation and the update of the section on implementation. Between 2017 and 2018, WHO re-assessed the evidence on the use of high FiO2 by updating the systematic review related to the effectiveness of this intervention to reduce SSI and commissioning an independent systematic review on adverse events potentially associated with it. Based on the updated evidence, the GDG decided to revise the strength of the recommendation from strong to conditional.
more
l’IMC et le gain de poids gestationnel sont des facteurs déterminants des risques de
résultats de grossesse, de la santé de la mère et de l’enfant. Cette étude analyse l’incidence de la
nutrition chez les femmes enceintes sur la santé néonatale au Bénin. Les résultats d’estimation... par les
équations simultanées montrent que le gain de poids gestationnel insuffisant ou excessif a des effets
néfastes aussi bien sur la santé de la mère que sur celui de l’enfant. L’étude montre que la majorité des
femmes béninoises étudiées, avec un IMC faible ou normal n’atteignent pas le gain de poids
gestationnel recommandé en fin de grossesse. La plupart des nouveau-nés de petits poids de naissance
sont nés de femme dont l’IMC est normal, ce qui renforce la théorie bien connue que l’IMC n’est pas un
bon indicateur de la malnutrition chez la femme enceinte.
more
IBOGA Review No.1 Revue Scientifique du Jésuites d'Afrique de l'Ouest
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do...cumento da OMS de 10 de fevereiro de 2021 Recomendações provisórias para o uso da vacina AZD1222 [ChAdOx1-S (recombinante)] contra COVID-19 desenvolvida pela Universidade de Oxford e pela AstraZeneca. Os dois documentos estão disponíveis na página sobre COVID-19 do SAGE: https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization/covid-19-materials. Têm sido usados vetores de adenovírus deficientes na replicação contendo um transgene específico do patógeno como novas vacinas devido à sua capacidade de induzir respostas humorais e celulares fortes.
more
A global Pandemic, Preparedness and Response (RRR) architecture
To provide a foundation for the strategic policy and programme development needed to ensure the sustainable implementation of effective interventions for reducing the global burden of PPH
A Learning Programme for Professionals
This manual was developed based on the recommendations of a global technical consultation on child health in humanitarian emergencies co-organized by WHO and UNICEF at the end of 2003. WHO in collaboration with the Centre for Refugee and Disaster Response, Bloomberg School of Public Health, Johns Ho...pkins University undertook a systematic review in 2004. It demonstrated that existing guidelines, including The Integrated Management of Childhood Illness (IMCI), do not cover all priority conditions in emergencies. The objective of this manual is to provide comprehensive guidance on child care in emergencies.
more
Guidelines for the Management of common childhood Illness. 2nd edition
These guidelines focus on the management of the major causes of childhood mortality in most developing countries, such as newborn problems, pneumonia, diarrhoea, malaria, meningitis, septicaemia, measles and related conditions, ...severe acute malnutrition and paediatric HIV/AIDS. It also covers common procedures, patient monitoring and supportive care on the wards and some common surgical conditions that can be managed in small hospitals.
A smart phone and tablet application is available from the Apple or Google Play Store.
Special attention is drawn to the following sections, which are particulary relevant within the COVID-19 context:
Chapter 4: information on cough and difficulty in breathing, pneumonia and bronchiolitis;
Chapter 10: information on essential supportive care including feeding, fluid and oxygen provision;
Annex 1: information on related practical procedures.
more